Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Zarate, C. A. Articles by Charney, D. S. Search for Related Content PubMed Citation Articles by Zarate, C. A., Jr. Articles by Charney, D. S. Depression Other Somatic Therapy

A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression

OBJECTIVE: This study was designed to assess possible antidepressant effects of memantine, a selective N-methyl-D-aspartate (NMDA) receptor antagonist in humans. METHOD: In a double-blind, placebo-controlled study, 32 subjects with major depression were randomly assigned to receive memantine (5–20 mg/day) (N=16) or placebo (N=16) for 8 weeks. Primary efficacy was assessed by performance on the Montgomery-Åsberg Depression Rating Scale (MADRS). RESULTS: The linear mixed models for total MADRS scores showed no treatment effect. CONCLUSIONS: In an 8-week trial, the low-to-moderate-affinity NMDA antagonist memantine in doses of 5–20 mg/day was not effective in the treatment of major depressive disorder.

This article has been cited by other articles:

				R. Machado-Vieira, H. K. Manji, and C. A. Zarate The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders Neuroscientist, October 1, 2009; 15(5): 525 - 539. [Abstract] [PDF]

				J. F. W. Deakin, J. Lees, S. McKie, J. E. C. Hallak, S. R. Williams, and S. M. Dursun Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco-Magnetic Resonance Imaging Study Arch Gen Psychiatry, February 1, 2008; 65(2): 154 - 164. [Abstract] [Full Text] [PDF]

				G. E. Tsai Searching for Rational Anti N-methyl-D-aspartate Treatment for Depression Arch Gen Psychiatry, September 1, 2007; 64(9): 1099 - 1100. [Full Text] [PDF]

				T. Kos, B. Legutko, W. Danysz, G. Samoriski, and P. Popik Enhancement of Antidepressant-Like Effects but Not Brain-Derived Neurotrophic Factor mRNA Expression by the Novel N-Methyl-D-aspartate Receptor Antagonist Neramexane in Mice J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1128 - 1136. [Abstract] [Full Text] [PDF]

				C. A. Zarate Jr, J. B. Singh, P. J. Carlson, N. E. Brutsche, R. Ameli, D. A. Luckenbaugh, D. S. Charney, and H. K. Manji A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. Arch Gen Psychiatry, August 1, 2006; 63(8): 856 - 864. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us